Erratum to "Comparative effects of sophocarpine and sophoridine on hERG K+ channel" [European Journal of Pharmacology 607 (2009) 15-22] (DOI:10.1016/j.ejphar.2009.02.013);Comparative effects of sophocarpine and sophoridine on hERG K+ channel

European Journal of Pharmacology

Volumn 607, Issue 1-3, 2009, Pages 15-22

  Zhao, Xue Ling ^a,c   Gu, Dong Fang ^a   Qi, Zhi Ping ^a   Chen, Ming Hong ^a   Wei, Ting ^a   Li, Bao Xin ^a,b   Yang, Bao Feng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b State Province Key Laboratory of Biopharmaceutical Engineering   (China)

^c HEILONGJIANG UNIVERSITY   (China)

Author keywords

HEK293 cell; hERG channel; Patch clamp; Sophocarpine; Sophoridine; Western blot

Indexed keywords

POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; QUINOLIZIDINE DERIVATIVE; SOPHOCARPINE; SOPHORIDINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; BINDING AFFINITY; CELL STRAIN HEK293; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENCY; EMBRYO; HUMAN; HUMAN CELL; HYDROPHOBICITY; PARTITION COEFFICIENT; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION; TEMPERATURE; WESTERN BLOTTING; WHOLE CELL;

EID: 62149131431     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.059     Document Type: Erratum

References (30)

1. Aronov A.M. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers. J. Med. Chem. 49 (2006) 6917-6921
2. Chen X., and Li Y.G. Effects of oxymatrine on sodium current in isolated ventricular cells in guinea-pig. J. N. Behtune Univ. Med. Sci. vol. 27 (2001) 41-42
3. Chen X., Yi C., Yang X., and Wang X. Liquid chromatography of active principles in Sophora flavescens root. J. Chromatogr., B. Anal. Technol. Biomed. Life Sci. 812 (2004) 149-163
4. Choe H., Nah K.H., Lee S.N., Lee H.S., Jo S.H., Leem C.H., and Jang Y.J. A novel hypothesis for the binding mode of HERG channel blockers. Biochem. Biophys. Res. Commun. 344 (2006) 72-78
5. Cordes J.S., Sun Z., Lloyd D.B., Bradley J.A., Opsahl A.C., Tengowski M.W., Chen X., and Zhou J. Pentamidine reduces hERG expression to prolong the QT interval. Br. J. Pharmacol. 145 (2005) 15-23
6. Du X., Lu D., Daharsh E.D., Yao A., Dewoody R., and Yao J.A. Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells. J. Pharmacol. Toxicol. Methods 54 (2006) 164-172
7. Ducroq J., Printemps R., Guilbot S., Gardette J., Salvetat C., and Le G.M. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. J. Pharmacol. Toxicol. Methods 56 (2007) 159-170
8. Eckhardt L.L., Rajamani S., and January C.T. Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome. Br. J. Pharmacol. 145 (2005) 3-4
9. Galasso V., Asaro F., Berti F., Pergolese B., Kovač B., and Pichierri F. On the molecular and electronic structure of matrine-type alkaloids. Chem. Phys. 330 (2006) 457-468
10. + channel blockers using GFA and HypoGen techniques. J. Mol. Graph. Model. 26 (2008) 966-976
11. Guo Z.B., Li Q., Cao H.Y., and Xu Z. Antiarrhythmic efficancy of neferine assessed by programmed electrical stimulation in a canine model of electropharmacology. Chin. Pharm. Sci. 11 (2002) 35-42
12. Karle C.A., Kreye V.A., Thomas D., Rockl K., Kathöfer S., Zhang W., and Kiehn J. Antiarrhythmic drug carvedilol inhibits HERG potassium channels. Cardiovasc. Res. 49 (2001) 361-370
13. Li Z.J., Zhao D.H., and Sheng B.H. Effects of sophoridine on experimental arrhythmias. Di Si Jun Yi Da Xue Xue Bao 7 (1986) 35-38
14. K, and HERG channels of cardiac myocytes. Acta Pharm. Sin. 22 (2001) 125-131
15. Milnes J.T., Crociani O., Arcangeli A., Hancox J.C., and Witchel H.J. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. Br. J. Pharmacol. 139 (2003) 887-898
16. Mitcheson J.S., Chen J., Lin M., Culberson C., and Sanguinetti M.C. A structural basis for drug-induced long QT syndrome. Proc. Natl. Acad. Sci. U. S. A. 22 (2000) 12329-12333
17. + channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br. J. Pharmacol. 149 (2006) 481-489
18. Redfern W.S., Carlsson L., Davis A.S., Lynch W.G., MacKenzie I., Palethorpe S., Siegl P.K.S., Strang I., Sullivan A.T., Wallis R., Camm A.J., and Hammond T.G. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58 (2003) 32-45
19. Sanguinetti M.C., and Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 440 (2006) 463-469
20. i in single ventricular myocyte of guinea pig. Chin. Pharm. J. 39 (2004) 264-266
21. Xu C.Q., Dong D.L., Du Z.W., Chen Q.W., Gong D.M., and Yang B.F. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866. Yao Xue Xue Bao vol. 39 (2004) 691-694
22. Yalta K., Turgut O., Yilmaz A., Yilmaz M.B., Kendirlioglu O., and Karadas F. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Int. J. Cardiol. 116 (2007) e95-e97
23. Zhang Y., Liu Y.Y., Wang T., Li B.X., Li H.W., Wang Z.G., and Yang B.F. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun. 340 (2006) 1192-1199
24. Zhang Y., Du J., Zhang Y., Sun H.L., Pan Z.W., Lu Y.J., Li B.X., and Yang B.F. Effects of matrine, oxymatrine and resveratrol on HERG channel expression. Yao Xue Xue Bao vol. 42 (2007) 139-144
25. Zhao Z.Y., Li Y.Q., and Lin Z.Y. The antiarrhythmic action of sophocarpine hydrobromide. Acta Pharm. Sin. 4 (1983) 173-176
26. Zhao X.L., Qi Z.P., Fang C., Chen M.H., Lv Y.J., Li B.X., and Yang B.F. HERG k(+) channel blockade by the novel antiviral drug sophocarpine. Biol. Pharm. Bull. 31 (2008) 627-632
27. Zhou Z., Gong Q., Ye B., Fan Z., Makielski J.C., Robertson G.A., and January C.T. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J. 74 (1998) 230-241
28. Zhou Z., Gong Q., and January C.T. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. J. Biol. Chem. 274 (1999) 31123-31126
29. Zitron E., Karle C.A., Wendt-Nordahl G., Kathöfer S., Zhang W., Thomas D., Weretka S., and Kiehn J. Bertosamil blocks HERG potassium channels in their open and inactivated states. Br. J. Pharmacol. 137 (2002) 221-228
30. Zitron E., Kiesecker C., Scholz E., Lück S., Bloehs R., Kathöfer S., Thomas D., Kiehn J., Kreye V.A., Katus H.A., Schoels W., and Karle C.A. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Naunyn-Schmiedeberg's Arch. Pharmacol. 370 (2004) 146-156